BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Obesity
,
Adipose tissue
,
Anticancer prodrugs
,
Fluoxetine
,
rs7903146
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hu 211
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
Breast cancer MDA-MB-468, MDA-MB-231, and MDA-MB-157 cells with thalidomide, BETi-211, or BETd-246
Hematopoietic stem/progenitor cell (HSPC) subtypes from multiple myeloma or healthy individuals
Gene expression profiling of CD34+ subsets in CML and healthy individuals
Explore Curated Studies Results
Literature
Most Relevant Literature
Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corti…
Syntheses of Cannabinoid Metabolites: Ajulemic Acid and HU-210.
Hippocampal CB1 receptor mediates antidepressant-like effect of synthetic cannabinoid-HU210 in acute…
Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior.
Differential regulation of Cav 3.2 and Cav 2.2 calcium channels by CB1 receptors and cannabidiol.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters
Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines
AR-inhibitor Bicalutamide in Treating Patients With TNBC
Sarcopenia and Physiology Assessments in Cancer Patients
Effectiveness of Group CBT in Children With Mixed Psychiatric Disorders
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ